Cited by CrossRef (14)
- Haifeng Eishingdrelo, Xiaofa Qin, Luwa Yuan, Sathapana Kongsamut, Lei Yu. Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms. Current Research in Pharmacology and Drug Discovery 2022;3:100123

- Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, Katarzyna Urbańska, Filip Ambrozkiewicz, Andrzej Kwiatkowski, Lidia Martyńska, Anita Domańska, Wojciech Bik, Agnieszka Paziewska. Obesity as a Risk Factor for Breast Cancer—The Role of miRNA. IJMS 2022;23:15683

- Cristina M. Pedrero-Prieto, Javier Frontiñán-Rubio, Francisco J. Alcaín, Mario Durán-Prado, Juan R. Peinado, Yoana Rabanal-Ruiz. Biological Significance of the Protein Changes Occurring in the Cerebrospinal Fluid of Alzheimer’s Disease Patients: Getting Clues from Proteomic Studies. Diagnostics 2021;11:1655

- Xianlong Huang, Zhiwen Zheng, Yixin Wu, Meng Gao, Zhengding Su, Yongqi Huang. 14-3-3 Proteins are Potential Regulators of Liquid–Liquid Phase Separation. Cell Biochem Biophys 2022;80:277

- Yue Zhang, Bo Luo, Mei-Chen Liu, Ren-Hui OuYang, Xian-Min Fan, Nan Jiang, Feng-Jiao Yang, Ling-Jun Wang, Bi-Ying Zhou. Analysis of immune response in BALB/c mice immunized with recombinant plasmids pMZ-X3-Ts14–3–3.3 and pMZ-X3-sp-Ts14–3–3.3 of Taenia solium. Acta Tropica 2022;232:106517

- Debbie Chong, Nigel C. Jones, Ralf B. Schittenhelm, Alison Anderson, Pablo M. Casillas-Espinosa. Multi-omics integration and epilepsy: Towards a better understanding of biological mechanisms. Progress in Neurobiology 2023;227:102480

- Sathapana Kongsamut, Haifeng Eishingdrelo. Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery. Drug Discovery Today 2023;28:103641

- Jaya Aseervatham. Interactions between 14-3-3 Proteins and Actin Cytoskeleton and Its Regulation by microRNAs and Long Non-Coding RNAs in Cancer. Endocrines 2022;3:665

- Akshatha Ganne, Meenakshisundaram Balasubramaniam, Nirjal Mainali, Paavan Atluri, Robert J. Shmookler Reis, Srinivas Ayyadevara. Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases. IJMS 2022;23:15457

- Eunsil Cho, Jinsil Park, Eun Mi Hwang, Hyung Wook Kim, Jae-Yong Park. 14-3-3γ haploinsufficiency leads to altered dopamine pathway and Parkinson’s disease-like motor incoordination in mice. Mol Brain 2023;16

- Santiago Rodriguez Ospina, Danielle Blazier, Marangelie Criado-Marrero, Lauren Gould, Niat Gebru, David Beaulieu-Abdelahad, Xinming Wang, Elizabeth Remily-Wood, Dale Chaput, Stanley Stevens, Vladimir Uversky, Paula Bickford, Chad Dickey, Laura Blair. Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain. IJMS 2022;23:851

- Ronnita C. Sequeira, Angel Godad. An update on microRNA as a potential blood-based biomarker for Alzheimer’s disease. Nucleus 2023

- Jing Wang, Xiaotao Pan, Jie Li, Jin Zhao. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG. Mol Med Rep 2022;25

- Haiying Mao, Lei Cao, Ting Xu, Xiaohan Xia, Peilei Ren, Pengfei Han, Chengfei Li, Xianfeng Hui, Xian Lin, Kun Huang, Meilin Jin. YWHAG inhibits influenza a virus replication by suppressing the release of viral M2 protein. Front. Microbiol. 2022;13
